Showing 1 - 3 results of 3 for search 'Odette Allonby', query time: 0.02s
Refine Results
-
1
589 RUBY trial post hoc analysis of number needed to treat and incremental costs per outcome of dostarlimab + carboplatin-paclitaxel (CP) vs placebo + CP for primary advanced/recur... by Llenalia Garcia-Fernandez, Jean Hurteau, Lydia Lee, Solomon J Lubinga, Tilman Payer, Meghann Gregg, Odette Allonby
Published 2023-11-01Article -
2
588 Dostarlimab + chemotherapy for the treatment of primary advanced or recurrent endometrial cancer (pA/rEC) in the RUBY trial: post hoc analysis of the costs of grade ≥3 adverse... by Llenalia Garcia-Fernandez, Jean Hurteau, Lydia Lee, Solomon J Lubinga, Tilman Payer, Meghann Gregg, Odette Allonby
Published 2023-11-01Article -
3
Understanding Characteristics, Treatment Patterns, and Clinical Outcomes for Individuals with Advanced or Recurrent Endometrial Cancer in Alberta, Canada: A Retrospective, Populati... by Diana Martins, Dylan E. O’Sullivan, Devon J. Boyne, Winson Y. Cheung, Odette Allonby, Mara Habash, Darren R. Brenner, Justin Riemer, Jacob McGee
Published 2023-02-01
Article